© The Financial Times Ltd 2015 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
A British company has positioned itself to lead the growing multibillion-dollar market for unlicensed pharmaceuticals byAndrew Ward, Pharmaceuticals Correspondent
Looking out from the sliver of Texas that he represents, running from San Antonio to Laredo and the Mexican border, HenryShawn Donnan in Washington
Having entered 2015 in a bullish mood, the US Federal Reserve’s top policy makers are now acknowledging a run of weaker dataSam Fleming in Washington
Argentine President Cristina Fernández’s jokes were lost in translation when she sought to win over a group of bemusedBenedict Mander in Buenos Aires
US banks and asset managers are pushing for a delay in reporting big corporate bond trades as a way of avoiding a possibleRobin Wigglesworth, US Markets Editor
The threshold required to become one of the 1,000 richest people based in Britain hit £100m in 2015, as record highs onElizabeth Paton
For decades, warring Bangladeshi politicians have been able to rely on a safety valve when the pressure rises and anVictor Mallet
I do not normally move in the company of boxers, probably because of fear of a left hook to the kidneys, but I was fortunateJurek Martin
To be a billionaire, the first thing you need is a personality disorder. That is what I had always assumed, based on my ownLucy Kellaway
Leo McKee is ruminating on his voting intentions in next month’s general election. The chief executive of BrightHouse, theEmma Jacobs
Video clips that closely match your search
John Authers looks forward to a packed week of many ess...
Bank considers location of headquarters
Martin Sandbu on why it matters